Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Articles published by Gyre Therapeutics, Inc.

Gyre Therapeutics Reports Third Quarter 2024 and Year-To-Date Financial Results and Provides Business Update
From Gyre Therapeutics, Inc.
Via GlobeNewswire
Tickers GYRE
Gyre Therapeutics Announces Last Patient Completed Pivotal Phase 3 Trial Evaluating F351 for CHB-Associated Liver Fibrosis
From Gyre Therapeutics, Inc.
Via GlobeNewswire
Tickers GYRE
Gyre Therapeutics to Present at 8th Annual H.C. Wainwright MASH Investor Conference
From Gyre Therapeutics, Inc.
Via GlobeNewswire
Tickers GYRE
Gyre Therapeutics to Present at H.C. Wainwright 26th Annual Global Investment Conference
From Gyre Therapeutics, Inc.
Via GlobeNewswire
Tickers GYRE
Gyre Therapeutics Reports Second Quarter 2024 and Year-To-Date Financial Results and Provides Business Update
From Gyre Therapeutics, Inc.
Via GlobeNewswire
Tickers GYRE
Gyre Therapeutics to Present at Sidoti Virtual Investor Conference
From Gyre Therapeutics, Inc.
Via GlobeNewswire
Tickers GYRE
Gyre Therapeutics Announces Appointment of David M. Epstein, Ph.D., to Board of Directors
From Gyre Therapeutics, Inc.
Via GlobeNewswire
Tickers BDTX GYRE
Gyre Therapeutics Announces China’s NMPA Approval of Avatrombopag Maleate Tablets for the Treatment of CLD-Associated Thrombocytopenia
From Gyre Therapeutics, Inc.
Via GlobeNewswire
Tickers GYRE
Gyre Therapeutics Announces Publication in Journal of Gastroenterology and Hepatology
From Gyre Therapeutics, Inc.
Via GlobeNewswire
Tickers GYRE
Gyre Pharmaceuticals Receives IND Approval from China’s NMPA to Evaluate F230 for the Treatment of Pulmonary Arterial Hypertension
From Gyre Therapeutics, Inc.
Via GlobeNewswire
Tickers GYRE
Gyre Therapeutics Announces Expected Addition to the Russell 2000® and Russell 3000® Indexes
From Gyre Therapeutics, Inc.
Via GlobeNewswire
Tickers GYRE
Gyre Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Update
From Gyre Therapeutics, Inc.
Via GlobeNewswire
Tickers GYRE
Gyre Therapeutics Reports Full Year 2023 Financial Results and Provides Business Update
From Gyre Therapeutics, Inc.
Via GlobeNewswire
Tickers GYRE
Gyre Therapeutics Expands Board of Directors with Appointment of Rodney L. Nussbaum
From Gyre Therapeutics, Inc.
Via GlobeNewswire
Tickers GYRE
Gyre Therapeutics Presents Poster at the American Association for the Study of Liver Diseases (AASLD) Annual Liver Meeting
From Gyre Therapeutics, Inc.
Via GlobeNewswire
Tickers GYRE
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.